New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - bimatoprost 0.3 mg/ml - eye drops, solution - 0.3 mg/ml - active: bimatoprost 0.3 mg/ml excipient: citric acid monohydrate dibasic sodium phosphate heptahydrate hydrochloric acid sodium chloride sodium hydroxide water for injection - indicated as monotherapy for the reduction of elevated intraocular pressure (iop) in patients with chronic glaucoma or ocular hypertension; or as adjunctive therapy in patients not adequately controlled on other agents.

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

abbvie deutschland gmbh, germany - timolol maleate,bimatoprost - eye drops, solution - 5,0.3 mg/ml,

Singapore - English - HSA (Health Sciences Authority)

abbvie pte. ltd. - bimatoprost; timolol maleate 6.8 mg/ml eqv timolol - solution, sterile - bimatoprost 0.3 mg/ml; timolol maleate 6.8 mg/ml eqv timolol 5 mg/ml

Israel - English - Ministry of Health

teva israel ltd - bimatoprost; timolol as maleate - eye drops, solution - timolol as maleate 5 mg / 1 ml; bimatoprost 0.3 mg / 1 ml - timolol, combinations - reduction of intraocular pressure in patients with open- angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

allergan malaysia sdn bhd - bimatoprost; timolol maleate -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

abbvie sdn bhd - bimatoprost; timolol maleate -

New Zealand - English - Medsafe (Medicines Safety Authority)

abbvie limited - bimatoprost 0.1 mg/ml;   - eye drops, solution - 0.1 mg/ml - active: bimatoprost 0.1 mg/ml   excipient: benzalkonium chloride citric acid monohydrate dibasic sodium phosphate heptahydrate hydrochloric acid purified water sodium chloride sodium hydroxide - lumigan rc™ is indicated as monotherapy for the reduction of elevated intraocular pressure (iop) in patients with chronic glaucoma or ocular hypertension; or as adjunctive therapy in patients not adequately controlled on other agents.

Israel - English - Ministry of Health

allergan israel ltd - bimatoprost - ophthalmic solution - bimatoprost 0.3 mg/ml - bimatoprost - bimatoprost - reduction of elevated intraocular pressure in chronic open angle glaucoma and ocular hypertension (as monotherapy or as adjunctive therapy to beta-blockers).

European Union - English - EMA (European Medicines Agency)

allergan pharmaceuticals ireland - bimatoprost, timolol - glaucoma, open-angle, ocular hypertension - ophthalmologicals, - reduction of intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

sun pharmaceutical industries limited, india - bimatoprost ophthalmic solution - eye drops - 0.03% w/v